[Malignant transformation of Ollier disease-related multiple glioma with IDH1 p.R132C mutation].

Q4 Medicine
Clinical Neurology Pub Date : 2024-07-27 Epub Date: 2024-06-20 DOI:10.5692/clinicalneurol.cn-001955
Gen Watanabe, Yu Fujii, Yoshiki Hanaoka, Miyuki Tanaka, Mai Iwaya, Tetsuyoshi Horiuchi
{"title":"[Malignant transformation of Ollier disease-related multiple glioma with IDH1 p.R132C mutation].","authors":"Gen Watanabe, Yu Fujii, Yoshiki Hanaoka, Miyuki Tanaka, Mai Iwaya, Tetsuyoshi Horiuchi","doi":"10.5692/clinicalneurol.cn-001955","DOIUrl":null,"url":null,"abstract":"<p><p>A 21-year-old man who was diagnosed with Ollier disease at the age of 1 year developed incidental multiple gliomas at the age of 15 years. Subsequently, the multiple gliomas enlarged and the patient underwent three surgical removals. Genetic analysis revealed the IDH1 p.R132C mutation in the gliomas, and histopathology showed malignant transformation. Despite multimodality treatment, the gliomas could not be controlled, and the patient died at the age of 23 years. Ollier disease is a rare disease with IDH1/2 mutations and is often associated with gliomas. However, there are very few reports on genetic analysis of IDH1/2 mutations and long-term follow-up in Ollier disease-related gliomas. Genetic analysis of IDH mutations may contribute to the elucidation of its pathogenesis. The cross-departmental collaboration is required for long-term follow-up of Ollier disease-related gliomas.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"474-479"},"PeriodicalIF":0.0000,"publicationDate":"2024-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Neurology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5692/clinicalneurol.cn-001955","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

A 21-year-old man who was diagnosed with Ollier disease at the age of 1 year developed incidental multiple gliomas at the age of 15 years. Subsequently, the multiple gliomas enlarged and the patient underwent three surgical removals. Genetic analysis revealed the IDH1 p.R132C mutation in the gliomas, and histopathology showed malignant transformation. Despite multimodality treatment, the gliomas could not be controlled, and the patient died at the age of 23 years. Ollier disease is a rare disease with IDH1/2 mutations and is often associated with gliomas. However, there are very few reports on genetic analysis of IDH1/2 mutations and long-term follow-up in Ollier disease-related gliomas. Genetic analysis of IDH mutations may contribute to the elucidation of its pathogenesis. The cross-departmental collaboration is required for long-term follow-up of Ollier disease-related gliomas.

[IDH1 p.R132C突变的奥利尔病相关多发性胶质瘤的恶性转化]。
一名 21 岁男子在 1 岁时被诊断出患有奥利埃病,15 岁时偶然患上多发性胶质瘤。随后,多发性胶质瘤增大,患者接受了三次手术切除。基因分析显示胶质瘤中存在 IDH1 p.R132C 突变,组织病理学显示为恶性转化。尽管接受了多模式治疗,但胶质瘤仍未能得到控制,患者在 23 岁时去世。奥利尔病是一种罕见的 IDH1/2 基因突变疾病,通常与胶质瘤相关。然而,关于 IDH1/2 基因突变的遗传分析以及对奥利尔病相关胶质瘤进行长期随访的报道却寥寥无几。对IDH突变的基因分析可能有助于阐明其发病机制。奥利埃病相关胶质瘤的长期随访需要跨部门合作。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Neurology
Clinical Neurology Medicine-Neurology (clinical)
CiteScore
0.30
自引率
0.00%
发文量
147
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信